MedX Health Corp
MDXHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $490 | $456 | $511 | $563 |
| % Growth | 7.4% | -10.7% | -9.3% | – |
| Cost of Goods Sold | $295 | $270 | $271 | $274 |
| Gross Profit | $194 | $186 | $240 | $289 |
| % Margin | 39.7% | 40.7% | 47% | 51.4% |
| R&D Expenses | $526 | $586 | $682 | $995 |
| G&A Expenses | $1,667 | $1,662 | $1,796 | $2,076 |
| SG&A Expenses | $1,673 | $2,216 | $2,942 | $3,547 |
| Sales & Mktg Exp. | $6 | $555 | $1,146 | $1,471 |
| Other Operating Expenses | $299 | $408 | $485 | $310 |
| Operating Expenses | $2,498 | $3,211 | $4,108 | $4,852 |
| Operating Income | -$2,304 | -$3,025 | -$3,868 | -$4,563 |
| % Margin | -470.4% | -663.3% | -757.6% | -810.3% |
| Other Income/Exp. Net | -$1,349 | -$1,556 | -$1,265 | -$761 |
| Pre-Tax Income | -$3,653 | -$4,581 | -$5,134 | -$5,324 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,653 | -$4,581 | -$5,134 | -$5,324 |
| % Margin | -746% | -1,004.3% | -1,005.4% | -945.4% |
| EPS | -0.014 | -0.023 | -0.028 | -0.03 |
| % Growth | 41.2% | 16.5% | 5.4% | – |
| EPS Diluted | -0.014 | -0.023 | -0.028 | -0.03 |
| Weighted Avg Shares Out | 266,720 | 196,708 | 183,742 | 180,185 |
| Weighted Avg Shares Out Dil | 266,720 | 196,708 | 183,742 | 180,185 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1,349 | $2,150 | $1,269 | $778 |
| Depreciation & Amortization | $47 | $52 | $52 | $52 |
| EBITDA | -$2,257 | -$2,379 | -$3,817 | -$4,541 |
| % Margin | -460.9% | -521.5% | -747.5% | -806.4% |